CIT  
MapMap English Français
  CIT Home page CIT Services News and Events CIT Publications Careers Contact
Search on CIT website  
Safety & Health Research Laboratories


Functional genomics

The FDA Critical Path Initiative has identified toxicogenomics as one of the key opportunities in advancing medical product development. Indeed, transcriptomics (the evaluation of messenger RNA modulation by drugs) is one of the most effective tools to elucidate toxic mechanisms and to predict toxicity.

Toxicogenomics is now a standard tool for early detection of safety issues during the discovery phases in pharmaceutical research and development.

  • Biomarker discovery
  • Generation of toxicity signature databases
  • Mechanistic toxicology
  • Ranking compounds by gene expression profile comparisons
  • Early predictive toxicology by comparison with Drug Toxicity signature databases

_______________________________________________________________


CIT's services


CIT proposes a complete integrated toxicogenomics solution from in vivo studies to
data mining, including:

These studies are conducted according to the highest quality standards.



  Choose a service description
Short term, tolerance and in-vitro toxicology
Genetic toxicology
General toxicology
Reprotoxicology
Carcinogenicity testing
Safety and general pharmacology
ADME and Bioanalysis
Clinical and Histopathology
Genomics
Ecotoxicology
Pharmaceutical analysis and stability testing
Project Management and Regulatory Affairs
 
 
© All rights reserved to CIT Site Map  |  Privacy & Terms